Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Deferred Taxes (2020 - 2021)

Celularity (CELU) has disclosed Deferred Taxes for 2 consecutive years, with $3000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Deferred Taxes rose 103.75% to $3000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$1.4 million, a 84.05% increase, with the full-year FY2022 number at -$1000.0, up 99.93% from a year prior.
  • Deferred Taxes was $3000.0 for Q4 2021 at Celularity, up from -$1.3 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $91930.0 in Q1 2020 to a low of -$8.4 million in Q3 2020.